open access

Vol 91, No 3 (2020)
REVIEW PAPERS Gynecology
Published online: 2020-03-31
Get Citation

Minimally invasive surgery for uterine fibroids

Yuehan Wang, Shitai Zhang, Chenyang Li, Bo Li, Ling Ouyang
DOI: 10.5603/GP.2020.0032
·
Pubmed: 32266956
·
Ginekol Pol 2020;91(3):149-157.

open access

Vol 91, No 3 (2020)
REVIEW PAPERS Gynecology
Published online: 2020-03-31

Abstract

The incidence of uterine fibroids, which comprise one of the most common female pelvic tumors, is almost 70–75% for
women of reproductive age. With the development of surgical techniques and skills, more individuals prefer minimally
invasive methods to treat uterine fibroids. There is no doubt that minimally invasive surgery has broad use for uterine
fibroids. Since laparoscopic myomectomy was first performed in 1979, more methods have been used for uterine fibroids,
such as laparoscopic hysterectomy, laparoscopic radiofrequency volumetric thermal ablation, and uterine artery embolization,
and each has many variations. In this review, we compared these methods of minimally invasive surgery for uterine
fibroids, analyzed their benefits and drawbacks, and discussed their future development.

Abstract

The incidence of uterine fibroids, which comprise one of the most common female pelvic tumors, is almost 70–75% for
women of reproductive age. With the development of surgical techniques and skills, more individuals prefer minimally
invasive methods to treat uterine fibroids. There is no doubt that minimally invasive surgery has broad use for uterine
fibroids. Since laparoscopic myomectomy was first performed in 1979, more methods have been used for uterine fibroids,
such as laparoscopic hysterectomy, laparoscopic radiofrequency volumetric thermal ablation, and uterine artery embolization,
and each has many variations. In this review, we compared these methods of minimally invasive surgery for uterine
fibroids, analyzed their benefits and drawbacks, and discussed their future development.

Get Citation

Keywords

minimally invasive surgery; uterine fibroid; laparoscopic hysterectomy; laparoscopic myomectomy

About this article
Title

Minimally invasive surgery for uterine fibroids

Journal

Ginekologia Polska

Issue

Vol 91, No 3 (2020)

Pages

149-157

Published online

2020-03-31

DOI

10.5603/GP.2020.0032

Pubmed

32266956

Bibliographic record

Ginekol Pol 2020;91(3):149-157.

Keywords

minimally invasive surgery
uterine fibroid
laparoscopic hysterectomy
laparoscopic myomectomy

Authors

Yuehan Wang
Shitai Zhang
Chenyang Li
Bo Li
Ling Ouyang

References (50)
  1. Lee CL, Wang CJ. Laparoscopic Myomectomy. Taiwanese Journal of Obstetrics and Gynecology. 2009; 48(4): 335–341.
  2. Huang HY, Liu YC, Li YC, et al. Comparison of three different hemostatic devices in laparoscopic myomectomy. J Chin Med Assoc. 2018; 81(2): 178–182.
  3. Bhave Chittawar P, Franik S, Pouwer AW, et al. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014(10): CD004638.
  4. Bojahr B, De Wilde RL, Tchartchian G. Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH). Arch Gynecol Obstet. 2015; 292(3): 665–672.
  5. Macciò A, Kotsonis P, Lavra F, et al. Laparoscopic removal of a very large uterus weighting 5320 g is feasible and safe: a case report. BMC Surg. 2017; 17(1): 50.
  6. Cianci S, Gueli Alletti S, Rumolo V, et al. Total laparoscopic hysterectomy for enlarged uteri: factors associated with the rate of conversion to open surgery. J Obstet Gynaecol. 2019; 39(6): 805–810.
  7. Shiota M, Kotani Y, Umemoto M, et al. Indication for laparoscopically assisted vaginal hysterectomy. JSLS. 2011; 15(3): 343–345.
  8. McGurk L, Oliver R, Odejinmi F. Laparoscopic supracervical hysterectomy for the larger uterus (>500 g): a case series and literature review. Arch Gynecol Obstet. 2017; 295(2): 397–405.
  9. Yuan H, Wang C, Wang D, et al. Comparing the effect of laparoscopic supracervical and total hysterectomy for uterine fibroids on ovarian reserve by assessing serum anti-mullerian hormone levels: a prospective cohort study. J Minim Invasive Gynecol. 2015; 22(4): 637–641.
  10. Wallwiener M, Taran FA, Rothmund R, et al. Laparoscopic supracervical hysterectomy (LSH) versus total laparoscopic hysterectomy (TLH): an implementation study in 1,952 patients with an analysis of risk factors for conversion to laparotomy and complications, and of procedure-specific re-operations. Arch Gynecol Obstet. 2013; 288(6): 1329–1339.
  11. Brucker SY, Taran FA, Bogdanyova S, et al. Patient-reported quality-of-life and sexual-function outcomes after laparoscopic supracervical hysterectomy (LSH) versus total laparoscopic hysterectomy (TLH): a prospective, questionnaire-based follow-up study in 915 patients. Arch Gynecol Obstet. 2014; 290(6): 1141–1149.
  12. Deslyn TG, et al. Hobson • Anthony N. Comparative analysis of different laparoscopic hysterectomy procedures. Arch Gynecol Obstet. 2012; 285: 1353–1361.
  13. Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25-40 years. Acta Obstet Gynecol Scand. 2000; 79(3): 202–207.
  14. Hu Y, Yu L, Xia F, et al. Effect of laparoscopic myomectomy on serum levels of IL-6 and TAC, and ovarian function. Exp Ther Med. 2019; 18(5): 3588–3594.
  15. Kotani Y, Tobiume T, Fujishima R, et al. Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy. J Obstet Gynaecol Res. 2018; 44(2): 298–302.
  16. Stoica RA, Bistriceanu I, Sima R. Laparoscopic myomectomy . Journal of Medicine and Life. 2014; 7(4): 522–524.
  17. Ksiezakowska-Lakoma K, Zyla K, Wilczynski J. Removal of uterine fibroids by mini-laparotomy technique in women who wish to preserve their uterus and fertility. 2015; 10(4): 561–566.
  18. Yuen LT, Hsu LJ, Lee CL, et al. A modified suture technique for laparoscopic myomectomy. J Minim Invasive Gynecol. 2007; 14(3): 318–323.
  19. Sesti F, Pietropolli A, Sesti FF, et al. Uterine myomectomy: role of gasless laparoscopy in comparison with other minimally invasive approaches. Minim Invasive Ther Allied Technol. 2013; 22(1): 1–8.
  20. Kim SKi, Lee JiH, Lee JR, et al. Laparoendoscopic single-site myomectomy versus conventional laparoscopic myomectomy: a comparison of surgical outcomes. J Minim Invasive Gynecol. 2014; 21(5): 775–781.
  21. Kim TJ, Lee YY, Cha HH, et al. Single-port-access laparoscopic-assisted vaginal hysterectomy versus conventional laparoscopic-assisted vaginal hysterectomy: a comparison of perioperative outcomes. Surg Endosc. 2010; 24(9): 2248–2252.
  22. Kim SKi, Lee JiH, Lee JR, et al. Laparoendoscopic single-site myomectomy versus conventional laparoscopic myomectomy: a comparison of surgical outcomes. J Minim Invasive Gynecol. 2014; 21(5): 775–781.
  23. Choi JS, Kyung YS, Kim KH, et al. The four-trocar method for performing laparoscopically-assisted vaginal hysterectomy on large uteri. J Minim Invasive Gynecol. 2006; 13(4): 276–280.
  24. Kikuchi I, Kumakiri J, Matsuoka S, et al. Learning curve of minimally invasive two-port laparoscopic myomectomy. JSLS. 2012; 16(1): 112–118.
  25. Milad MP, Milad EA. Laparoscopic morcellator-related complications. J Minim Invasive Gynecol. 2014; 21(3): 486–491.
  26. Garry R. Laparoscopic morcellation: an acceptable risk or an Achilles heel? BJOG. 2015; 122(4): 458–460.
  27. Huang BS, Yang MH, Wang PH, et al. Oestrogen-induced angiogenesis and implantation contribute to the development of parasitic myomas after laparoscopic morcellation. Reprod Biol Endocrinol. 2016; 14(1): 64.
  28. Chikazawa K, Netsu S, Konno R. Myoma morcellation through the navel. Taiwan J Obstet Gynecol. 2015; 54(1): 106.
  29. Reich H. Laparoscopic MYOMECTOMY. In: Hutchins FL, Greenberg MD, editors. . Obstetrics and Gynecology Clinics of North America: Uterine Fibroids. 1995; 22: 756–780.
  30. De Grandi P, Chardonnens E, Gerber S. The morcellator knife: a new laparoscopic instrument for supracervical hysterectomy and morcellation. Obstet Gynecol. 2000; 95(5): 777–778.
  31. LEE B. Radiofrequency ablation of uterine leiomyomata: a new minimally invasive hysterectomy alternative. Obstetrics & Gynecology. 2002; 99(4): S9.
  32. Levine DJ, Berman JM, Harris M, et al. Sensitivity of myoma imaging using laparoscopic ultrasound compared with magnetic resonance imaging and transvaginal ultrasound. J Minim Invasive Gynecol. 2013; 20(6): 770–774.
  33. Brucker SY, Hahn M, Kraemer D, et al. Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy. Int J Gynaecol Obstet. 2014; 125(3): 261–265.
  34. Donnez J, Mathieu PE, Bassil S, et al. Laparoscopic myomectomy today. Fibroids: management and treatment: the state of the art. Hum Reprod. 1996; 11(9): 1837–1840.
  35. Galen DI, Pemueller RR, Leal JG, et al. Laparoscopic radiofrequency fibroid ablation: phase II and phase III results. JSLS. 2014; 18(2): 182–190.
  36. Brucker SY, Hahn M, Kraemer D, et al. Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy. Int J Gynaecol Obstet. 2014; 125(3): 261–265.
  37. Hahn M, Brucker S, Kraemer D, et al. Radiofrequency Volumetric Thermal Ablation of Fibroids and Laparoscopic Myomectomy: Long-Term Follow-up From a Randomized Trial. Geburtshilfe Frauenheilkd. 2015; 75(5): 442–449.
  38. Quinn SD, Gedroyc WM. Thermal ablative treatment of uterine fibroids. Int J Hyperthermia. 2015; 31(3): 272–279.
  39. Hai N, Ding X. Intrauterine adhesion after transvaginal ultrasound-guided radiofrequency myolysis. J Obstet Gynaecol Res. 2015; 41(11): 1851–1854.
  40. Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995; 346(8976): 671–672.
  41. Mavrelos D, Ben-Nagi J, Davies A, et al. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial. Hum Reprod. 2010; 25(9): 2264–2269.
  42. Kohi MP, Spies JB. Updates on Uterine Artery Embolization. Semin Intervent Radiol. 2018; 35(1): 48–55.
  43. Boosz A, Reimer P, Matzko M, et al. The Conservative and Interventional Treatment of Fibroids. Deutsches Aerzteblatt Online. 2014.
  44. Toor SS, Jaberi A, Macdonald DB, et al. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. AJR Am J Roentgenol. 2012; 199(5): 1153–1163.
  45. Sentilhes L, Vayssière C, Beucher G, et al. Delivery for women with a previous cesarean: guidelines for clinical practice from the French College of Gynecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2013; 170(1): 25–32.
  46. van der Kooij SM, Bipat S, et al. Uterine artery embo- lization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis. Am J Obstet Gynecol . 2011; 205: 317–318.
  47. Kim HS, Kim JW, Kim MK, et al. A randomized prospective trial of the postoperative quality of life between laparoscopic uterine artery ligation and laparoscopy-assisted vaginal hysterectomy for the treatment of symptomatic uterine fibroids: clinical trial design. Trials. 2009; 10: 8.
  48. Davis MR, Soliman AM, Castelli-Haley J, et al. Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids. J Womens Health (Larchmt). 2018; 27(10): 1204–1214.
  49. Karlsen K, Hrobjartsson A, Korsholm M, et al. Fertility after uterine artery embolization of fibroids: a systematic review. Arch Gynecol Obstet. 2018; 297(1): 13–25.
  50. Trumm CG, Stahl R, Clevert DA, et al. Magnetic resonance imaging-guided focused ultrasound treatment of symptomatic uterine fibroids: impact of technology advancement on ablation volumes in 115 patients. Invest Radiol. 2013; 48(6): 359–365.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl